95 related articles for article (PubMed ID: 7733991)
1. Site-directed mutagenesis of herpes simplex virus type 1 thymidine kinase opposes the importance of amino acid positions 251, 321 and 348 for selective recognition of substrate analogs.
Michael M; Fetzer J; Folkers G
Biochem Biophys Res Commun; 1995 Apr; 209(3):966-73. PubMed ID: 7733991
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.
Gustafson EA; Chillemi AC; Sage DR; Fingeroth JD
Antimicrob Agents Chemother; 1998 Nov; 42(11):2923-31. PubMed ID: 9797227
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase.
Kussmann-Gerber S; Kuonen O; Folkers G; Pilger BD; Scapozza L
Eur J Biochem; 1998 Jul; 255(2):472-81. PubMed ID: 9716390
[TBL] [Abstract][Full Text] [Related]
4. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity.
Kokoris MS; Black ME
Protein Sci; 2002 Sep; 11(9):2267-72. PubMed ID: 12192082
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis clarifies the substrate position within the three-dimensional model of the active site of herpes simplex virus type-1 thymidine kinase.
Michael M; Fetzer J; Folkers G
Eur J Biochem; 1994 Nov; 226(1):219-26. PubMed ID: 7957251
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the recombinant herpes simplex virus type 1 thymidine kinase with thymidine and aciclovir: a kinetic study.
Kussmann-Gerber S; Wurth C; Scapozza L; Pilger BD; Pliska V; Folkers G
Nucleosides Nucleotides; 1999 Mar; 18(3):311-30. PubMed ID: 10358938
[TBL] [Abstract][Full Text] [Related]
7. Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase.
Rechtin TM; Black ME; Mao F; Lewis ML; Drake RR
J Biol Chem; 1995 Mar; 270(13):7055-60. PubMed ID: 7706243
[TBL] [Abstract][Full Text] [Related]
8. Substrate diversity of herpes simplex virus thymidine kinase. Impact Of the kinematics of the enzyme.
Pilger BD; Perozzo R; Alber F; Wurth C; Folkers G; Scapozza L
J Biol Chem; 1999 Nov; 274(45):31967-73. PubMed ID: 10542226
[TBL] [Abstract][Full Text] [Related]
9. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.
Degrève B; Johansson M; De Clercq E; Karlsson A; Balzarini J
J Virol; 1998 Dec; 72(12):9535-43. PubMed ID: 9811686
[TBL] [Abstract][Full Text] [Related]
10. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
Degrève B; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
[TBL] [Abstract][Full Text] [Related]
11. Identification of important residues within the putative nucleoside binding site of HSV-1 thymidine kinase by random sequence selection: analysis of selected mutants in vitro.
Black ME; Loeb LA
Biochemistry; 1993 Nov; 32(43):11618-26. PubMed ID: 8218229
[TBL] [Abstract][Full Text] [Related]
12. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
Black ME; Newcomb TG; Wilson HM; Loeb LA
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3525-9. PubMed ID: 8622970
[TBL] [Abstract][Full Text] [Related]
13. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
Suzutani T; Davies LC; Honess RW
J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.
Hussein IT; Miguel RN; Tiley LS; Field HJ
Arch Virol; 2008; 153(3):495-505. PubMed ID: 18196203
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Wilber BA; Docherty JJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy.
Kokoris MS; Sabo P; Black ME
Anticancer Res; 2000; 20(2A):959-63. PubMed ID: 10810381
[TBL] [Abstract][Full Text] [Related]
17. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
[TBL] [Abstract][Full Text] [Related]
18. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase.
Black ME; Hruby DE
J Biol Chem; 1992 May; 267(14):9743-8. PubMed ID: 1577811
[TBL] [Abstract][Full Text] [Related]
20. A fast method for obtaining highly pure recombinant herpes simplex virus type 1 thymidine kinase.
Fetzer J; Michael M; Bohner T; Hofbauer R; Folkers G
Protein Expr Purif; 1994 Oct; 5(5):432-41. PubMed ID: 7827501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
